Clinical trial Recruiting at 1 site Interventional Ages 18 to 80

Using telemedicine to manage blood pressure in patients with controlled hypertension

Official title: Can TElemedicine System Replace Doctor Consultations to Achieve Non-inferior Blood Pressure in Patients With Controlled Hypertension (TEACH)? a Randomised Controlled Trial and Cost-minimization Analysis

Run by Chinese University of Hong Kong · NCT06524180 · Data updated 2026-11-12

This study tests if using telemedicine to manage blood pressure can work as well or better than regular doctor visits for people with controlled hypertension.

More Hypertension trials

Quick facts

Study typeInterventional
Ages18 Years to 80 Years
SexAll
Enrollment364 (estimated)
SponsorChinese University of Hong Kong
Academic / other
Locations1 site (Hong Kong, Hong Kong)
StatusRecruiting
StartedOctober 1, 2024
Main results expectedSeptember 30, 2027
Study endsSeptember 30, 2027
Registry record updatedDecember 10, 2025
Trial IDNCT06524180 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are individuals diagnosed with essential hypertension who are currently on antihypertensive medications and have well-controlled blood pressure.

Probably not a fit

Patients with uncontrolled hypertension or those not on antihypertensive medications may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial evaluates whether a telemedicine system can effectively manage blood pressure in patients with controlled hypertension compared to traditional in-person consultations. Participants in the telemedicine group will receive reminders for home blood pressure measurements and automatic medication refills, with consultations scheduled based on their blood pressure readings. The study aims to determine if telemedicine can achieve similar or better blood pressure control and healthcare utilization outcomes over a 12-month period compared to usual care.

Why it matters

Potential benefit: If successful, this approach could provide patients with a more convenient and efficient way to manage their hypertension.

How similar studies have gone: Previous studies have shown promising results with telemedicine approaches in managing chronic conditions, suggesting potential success for this method in hypertension management.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* (i) having a diagnosis of essential HT;
* (ii) on anti-HT medications;
* (iii) well-controlled HT on out-of-office BP measurements, including HBPM or ambulatory blood pressure measurements (ABPM) (measurement algorithm and details under methods). ABPM or HBPM are preferred to office BP due to their superior reproducibility and predictivity to cardiovascular outcomes. Furthermore, office BP misclassifies 30-40% of patients as having suboptimal BP control due to white-coat effect. From our pilot study, some patients with optimal BP are reluctant to undergo ABPM before recruitment into the RCT, and HBPM is more acceptable to these patients and is therefore included. According to local and international guidelines, optimal out-of-office daytime BP should be \<135/85 mmHg for patients without comorbidities and \<130/85 mmHg for patients with comorbidities that increase cardiovascular risk (i.e. stroke, ischaemic heart diseases, heart failure, diabetes mellitus (DM), and chronic kidney diseases) respectively;
* (iv) can read basic Chinese (language used in the HealthCap);
* (v) have used any mobile app (not HT-related) in the previous 1 year; and
* (vii) aged between 18-80.

Exclusion Criteria:

* (i) cannot provide informed consent;
* (ii) unwillingness to conduct HBPM or repeated ABPM;
* (iii) relative contraindications to ABPM (i.e., diagnosed atrial fibrillation, nighttime workers, occupational drivers, or patients with bleeding tendencies);
* (iv) have severe mental illnesses that impair their ability to use HealthCap, including those diagnosed with schizophrenia, dementia, or as being actively suicidal;
* (v) a diagnosis of other acute or chronic diseases that need regular physical assessments and/or medication changes (e.g., suboptimally controlled DM \[e.g., glycosylated haemoglobin (HbA1c)≥7%\], depression requiring medications, active cancer); and (vi) predicted lifespan of \<1 year.

Where it's running

  • HKW and NTEC GOPC
    Hong Kong, Hong Kong, Hong Kong
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.